Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
The Israel Medical Association Journal : IMAJ
|
May 8, 2020
The Effects of Adalimumab in Behçet Disease Patients on Clinical Manifestations and on Pro-Inflammatory Cytokines Milieu: Long-Term Follow-Up
Yolanda Braun-Moscovici, Yonit Tavor, Doron Markovits, et al.
The Journal of Rheumatology
|
October 10, 2008
Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis
Yolanda Braun-Moscovici, Daniel E Furst, Doron Markovits, et al.
Clinical Rheumatology
|
April 3, 2007
Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis
Alexandra Balbir-Gurman, Yolanda Braun-Moscovici, Vladimir Livshitz, et al.
Seminars in Arthritis and Rheumatism
|
August 2, 2011
Pulmonary arteries involvement in Takayasu's arteritis: two cases and literature review
Kohava Toledano, Ludmila Guralnik, Avraham Lorber, et al.
Annals of the Rheumatic Diseases
|
June 19, 2021
Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
Yolanda Braun-Moscovici, Marielle Kaplan, Maya Braun, et al.
Clinical and Experimental Rheumatology
|
September 5, 2022
Switching from intravenous tocilizumab to subcutaneous administration during COVID-19 pandemic: impact on treatment efficacy and patient satisfaction
Rula Daood, Kochava Toledano, Doron Markovits, et al.
Rheumatology International
|
December 15, 2012
Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience
Yolanda Braun-Moscovici, Yonatan Butbul-Aviel, Ludmila Guralnik, et al.
The Journal of Rheumatology
|
March 3, 2006
Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis
Yolanda Braun-Moscovici, Doron Markovits, Oren Zinder, et al.
Harefuah
|
August 9, 2017
[THE INPUT OF MEASURING INFLIXIMAB LEVELS AND LEVELS OF ANTIBODIES TO INFLIXIMAB IN THE MANAGEMENT OF PATIENTS WITH RHEUMATIC DISEASES]
Yolanda Braun-Moscovici, Amir Dagan, Kochava Toledano, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
December 21, 2010
Large leg ulcers due to autoimmune diseases
Alexander P Rozin, Dana Egozi, Yehuda Ramon, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
The Israel Medical Association Journal : IMAJ
|
May 8, 2020
The Effects of Adalimumab in Behçet Disease Patients on Clinical Manifestations and on Pro-Inflammatory Cytokines Milieu: Long-Term Follow-Up
Yolanda Braun-Moscovici, Yonit Tavor, Doron Markovits, et al.
The Journal of Rheumatology
|
October 10, 2008
Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis
Yolanda Braun-Moscovici, Daniel E Furst, Doron Markovits, et al.
Clinical Rheumatology
|
April 3, 2007
Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis
Alexandra Balbir-Gurman, Yolanda Braun-Moscovici, Vladimir Livshitz, et al.
Seminars in Arthritis and Rheumatism
|
August 2, 2011
Pulmonary arteries involvement in Takayasu's arteritis: two cases and literature review
Kohava Toledano, Ludmila Guralnik, Avraham Lorber, et al.
Annals of the Rheumatic Diseases
|
June 19, 2021
Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
Yolanda Braun-Moscovici, Marielle Kaplan, Maya Braun, et al.
Clinical and Experimental Rheumatology
|
September 5, 2022
Switching from intravenous tocilizumab to subcutaneous administration during COVID-19 pandemic: impact on treatment efficacy and patient satisfaction
Rula Daood, Kochava Toledano, Doron Markovits, et al.
Rheumatology International
|
December 15, 2012
Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience
Yolanda Braun-Moscovici, Yonatan Butbul-Aviel, Ludmila Guralnik, et al.
The Journal of Rheumatology
|
March 3, 2006
Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis
Yolanda Braun-Moscovici, Doron Markovits, Oren Zinder, et al.
Harefuah
|
August 9, 2017
[THE INPUT OF MEASURING INFLIXIMAB LEVELS AND LEVELS OF ANTIBODIES TO INFLIXIMAB IN THE MANAGEMENT OF PATIENTS WITH RHEUMATIC DISEASES]
Yolanda Braun-Moscovici, Amir Dagan, Kochava Toledano, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
December 21, 2010
Large leg ulcers due to autoimmune diseases
Alexander P Rozin, Dana Egozi, Yehuda Ramon, et al.
Page
of 3